Interventional Not yet recruiting
NCT06478810 on ClinicalTrials.gov
Ambulatory Surgery After Hepatectomy: Monitoring by Domomedicine Connected Tools and a Dedicated Nurse.
Official title: Ambulatory Surgery After Hepatectomy: Piloteasibility Study With Securing of the Post-operative Monitoring by Domomedicine Connected Tools and a Dedicated Nurse.
- Sponsor: Assistance Publique - Hôpitaux de Paris
- Enrollment: 20 (Estimated)
- Study start: 2024-09-01 (Estimated)
- Primary completion: 2025-12-04 (Estimated)
- Study completion: 2025-12-04 (Estimated)
- Allocation: N/a
- InterventionModel: Single Group
- Masking: None
- PrimaryPurpose: Other
Brief Summary
There are public health expectations for the development of outpatient surgery and increased comfort and quality of care for the patient. In this study, we are interested in evaluating the feasibility of an outpatient hepatectomy with a a close and secure follow-up at home: through a connected platform and a follow-up by a nurse. The primary endpoint is the rate of re-hospitalization due to a postoperative complication before Day 30 and the rate of conversion to conventional hospitalization (= early failure of outpatient management). This single-center study will includes prospectively 20 patients requiring liver resection of up to 2 segments. The primary endpoint is the rate of re-hospitalization due to a postoperative complication before Day 30 and the rate of conversion to conventional hospitalization (= early failure of outpatient management).
Conditions
- Liver Tumor
- Hepatectomy
Intervention / Treatment
- Other: Domomedicine and dedicated nursing care for a close and secure monitoring after an ambulatory hepatectomy
Primary Outcome Measures
-
Rate of re-hospitalization due to a postoperative complication before Day 30 and the rate of conversion to conventional hospitalization (= early failure of outpatient management).
(Day 30)
Rate of re-hospitalization due to a postoperative complication before Day 30 and the rate of conversion to conventional hospitalization.
Countries
France
Locations and Investigators
- Hepato-biliary surgery department, Villejuif, France
Study Officials
- Nicolas GOLSE (Principal Investigator) — Hepato-biliary surgery department, Paul Brousse hospital, APHP